The weekly litigation news digest is live. Subscribe now

Patent Oppositions in medical and personal care products industry

Explore the competitive field of medical and personal care products where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in medical and personal care products technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jan 15, 2026
CompanyTotal Oppositions
NOVARTIS300
BOEHRINGER INGELHEIM166
GLAXOSMITHKLINE108
AMGEN104
NOVO NORDISK96
PFIZER88
NUTRICIA83
NESTLE80
F HOFFMANN LA ROCHE73
NESTEC69

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the medical and personal care products industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the medical and personal care products industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jan 15, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 19, 2025HAMM & WITTKOPP
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEDec 8, 2025TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB
Composition Comprising Akkermansia Muciniphila And Green Tea ExtractTHE AKKERMANSIADec 5, 2025NESTLE
Dna-Pkcs Inhibitors For Increasing Genome Editing EfficiencyMAX PLANCK GESELLSCHAFT ZUR FRDERUNG DER WISSENSCHAFTEN EVDec 4, 2025MAIWALD
A Myostatin Pathway Inhibitor In Combination With A Glp-1 Pathway Activator For Use In Treating Metabolic DisordersSCHOLAR ROCKDec 3, 2025MARGARET DIXON
Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell FunctionF HOFFMANN LA ROCHENov 28, 2025SANDOZ
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERNov 26, 2025POHLMAN
Powders Containing A Buffer Salt And An Amino Acid, Reconstitution Of Such A Powder Into A Nutritional Product, And Methods Of Using Such A Nutritional ProductNESTLENov 25, 2025NUTRICIA

To stay ahead in the competitive medical and personal care products industry, companies are constantly innovating. Here are the top patents facing oppositions in the medical and personal care products industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jan 15, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS18
Oct 11, 2023New UseNOVARTIS17
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA13
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA12